Regulation of glucose homoeostasis by brown adipose tissue

The Lancet Diabetes and Endocrinology

Volumn 1, Issue 4, 2013, Pages 353-360

  Peirce, Vivian ^a   Vidal Puig, Antonio ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; BATOKINE; BETA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR BLOCKING AGENT; FIBROBLAST GROWTH FACTOR 21; INTERLEUKIN 6; LEPTIN; NORADRENALIN; OSTEOGENIC PROTEIN 1; PROSTAGLANDIN D2 SYNTHASE; SOMATOMEDIN C; SYNTHETASE; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL;

ADRENERGIC SYSTEM; ANTIDIABETIC ACTIVITY; AUTOCRINE EFFECT; B LYMPHOCYTE; BROWN ADIPOSE TISSUE; DYSLIPIDEMIA; ENERGY BALANCE; ENERGY EXPENDITURE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOLYSIS; LYMPHOCYTE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THERMOGENESIS; WEIGHT GAIN; WHITE ADIPOSE TISSUE; ANIMAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; HOMEOSTASIS; METABOLISM; OBESITY; PHYSIOLOGY; TRANSPLANTATION;

ADIPOSE TISSUE, BROWN; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; OBESITY;

EID: 84887619281     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70055-X     Document Type: Note

References (83)

1. Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009, 360:1509-1517.
2. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med 2009, 360:1518-1525.
3. Nedergaard J, Bengtsson T, Cannon B, et al. Unexpected evidence for active brown adipose tissue in adult humans. Am J Physiol Endocrinol Metab 2007, 293:E444-E452.
4. Saito M, Okamatsu-Ogura Y, Matsushita M, et al. High incidence of metabolically active brown adipose effects of cold exposure and adiposity. Diabetes 2009, 58:1526-1531.
5. Cannon B, Nedergaard J Brown adipose tissue: function and physiological significance. Physiol Rev 2004, 84:277-359.
6. Lelliott C, Vidal-Puig AJ Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Int J Obesity 2004, 28:S22-S28.
7. McGarry JD Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002, 51:7-18.
8. Kraegen EW, Cooney GJ, Ye JM, Thompson AL, Furler SM The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity. Exp Clin Endocrinol Diabetes 2001, 109(suppl):S189-S201.
9. Schaffer JE Lipotoxicity: when tissues overeat. Curr Opin Lipidol 2003, 14:281-287.
10. Papa FR Endoplasmic reticulum stress, pancreatic β-cell degeneration, and diabetes. Cold Spring Harb Perspect Med 2012, 2:1-17.
11. Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006, 355:2427-2443.
12. Holm C, Østerlund T, Laurell H, Contreras JA Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr 2000, 20:365-393.
13. Cousin B, Cinti S, Morroni M, et al. Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J Cell Sci 1992, 103:931-942.
14. Wu J, Boström P, Sparks LM, et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012, 150:366-376.
15. Timmons JA, Wennmalm K, Larsson O, et al. Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages. Proc Natl Acad Sci USA 2007, 104:4401-4406.
16. Shibata H, Perusse F, Vallerand A, Bukowiecki LJ Cold exposure reverses inhibitory effects of fasting on peripheral glucose uptake in rats. Am J Physiol 1989, 257:R96-101.
17. Vallerand AL, Perusse F, Bukowiecki LJ Stimulatory effects of cold exposure and cold acclimation on glucose uptake in rat peripheral tissues. Am J Physiol 1990, 259:R1043-R1049.
18. Vallerand AL, Lupien J, Bukowiecki LJ, Lupien J Interactions of cold exposure and starvation on glucose tolerance and insulin response. Am J Physiol 1983, 245:E575-E581.
19. Orava J, Nuutila P, Lidell ME, et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab 2011, 14:272-279.
20. Cannon B, Nedergaard J Nonshivering thermogenesis and its adequate measurement in metabolic studies. J Expl Biol 2011, 214:242-253.
21. Ouellet V, Routhier-Labadie A, Bellemare W, et al. Outdoor temperture, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake of 18F-FDG-detected BAT in humans. J Clin Endocrinol Metab 2011, 96:192-199.
22. Orava J, Nuutila P, Noponen T, et al. Blunted metabolic responses to cold and insulin stimulation in brown adipose tissue of obese humans. Obesity (Silver Spring) 2013, published online April 2. 10.1002/oby.20456.
23. Jacene HA, Cohade CC, Zhang Z, Wahl RL The relationship between patients' serum glucose levels and metabolically active brown adipose tissue detected by PET/CT. Mol Imaging Biol 2011, 13:1278-1283.
24. Lee P, Greenfield JR, Ho KKY, Fulham MJ A critical appraisal of the prevalence and metabolic significance of brown adipose tissue in adult humans. Am J Physiol 2010, 299:E601-E606.
25. Torp-Pedersen C, Caterson I, Coutinho W, et al. Cardiovascular responses to weight management and sibutramine in high-risk subjects: an analysis from the SCOUT trial. Eur Heart J 2007, 28:2915-2923.
26. Bartelt A, Bruns OT, Reimer R, et al. Brown adipose tissue activity controls triglyceride clearance. Nat Med 2011, 17:200-205.
27. Penn L, White M, Lindstrom J, et al. Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PLoS One 2003, 8:1-11.
28. Liu X, Pérusse F, Bukowiecki LJ Mechanisms of the antidiabetic effects of the β3-adrenergic agonist CL-316243 in obese Zucker-ZDF rats. Am J Physiol 1998, 274:R1212-R1219.
29. De Souza CJ, Hirshman MF, Horton ES CL-316,243, a beta3-specific adrenoceptor agonist, enhances insulin-stimulated glucose disposal in nonobese rats. Diabetes 1997, 46:1257-1263.
30. Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 2006, 116:1784-1792.
31. Arbeeny CM, Meyers DS, Hillyer DE, Bergquist KE Metabolic alterations associated with the antidiabetic effect of beta 3-adrenergic receptor agonists in obese mice. Am J Physiol 1995, 268:E678-E684.
32. Harlan SM, Morgan DA, Agassandian K, et al. Ablation of the leptin receptor in the hypothalamic arcuate nucleus abrogates leptin-induced sympathetic activation: novelty and significance. Circ Res 2011, 108:808-812.
33. Haque MS, Minokoshi Y, Hamai M, Iwai M, Horiuchi M, Shimazu T Role of the sympathetic nervous system and insulin in enhancing glucose uptake in peripheral tissues after intrahypothaalmic injection of leptin in rats. Diabetes 1999, 48:1706-1712.
34. Zhang Y, Kerman IA, Laque A, et al. Leptin-receptor-expressing neurons in the dorsomedial hypothalamus and median preoptic area regulate sympathetic brown adipose tissue circuits. J Neurosci 2011, 31:1873-1884.
35. Hynes GR, Jones PJ Leptin and its role in lipid metabolism. Curr Opin Lipidol 2001, 12:321-327.
36. Whittle AJ, Carobbio S, Martins L, et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell 2012, 149:871-885.
37. Villarroya J, Cereijo R, Villarroya F An endocrine role for brown adipose tissue?. Am J Physiol 2013, published online July 9. 10.1152/ajpendo.00250.2013.
38. Hondares E, Iglesias R, Giralt A, et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J Biol Chem 2011, 286:12983-12990.
39. Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005, 115:1627-1635.
40. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab 2007, 5:426-437.
41. Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab 2007, 5:415-425.
42. Burýšek L, Houštěk J β-Adrenergic stimulation of interleukin-1α and interleukin-6 expression in mouse brown adipocytes. FEBS Lett 1997, 411:83-86.
43. Mohamed-Ali V, Flower L, Sethi J, et al. Beta-adrenergic regulation of IL-6 release from adipose tissue: in vivo and in vitro studies. J Clin Endocrinol Metab 2001, 86:5864-5869.
44. Schöbitz B, de Kloet ER, Sutanto W, Holsboer F Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci 1993, 5:1426-1435.
45. Li G, Klein RL, Matheny M, King MA, Meyer EM, Scarpace PJ Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats. Neuroscience 2002, 115:879-889.
46. Wallenius V, Wallenius K, Ahren B, et al. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 2002, 8:75-79.
47. Virtue S, Feldmann H, Christian M, et al. A new role for lipocalin prostaglandin D synthase in the regulation of brown adipose tissue substrate utilization. Diabetes 2012, 61:3139-3147.
48. Virtue S, Masoodi M, Velagapudi V, et al. Lipocalin prostaglandin D synthase and PPARγ2 coordinate to regulate carbohydrate and lipid metabolism in vivo. PloS One 2012, 7:e39512.
49. Guerra C, Navarro P, Valverde AM, et al. Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J Clin Invest 2001, 108:1205-1213.
50. Valverde AM Role of insulin in the biology of the fetal brown adipocyte. Av Diabetol 2002, 18:145-151.
51. Yoshida T The antidiabetic beta3-adrenoceptor works by release of endogenous insulin. Am J Clin Nutr 1992, 55:237S-241S.
52. Grujic D, Susulic VS, Harper M, et al. Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. J Biol Chem 1997, 272:17686-17693.
53. Vallerand AL, Lupien J, Bukowiecki LJ Cold exposure reverses the diabetogenic effects of high-fat feeding. Diabetes 1986, 35:329-334.
54. Himms-Hagen J, Cui J, Danforth E, et al. Effect of CL-316,243, a thermogenic beta 3-agonist, on energy balance and brown and white adipose tissues in rats. Am J Physiol 1994, 266:R1371-R1382.
55. Darimont C, Turini M, Epitaux M, et al. β3-adrenoceptor agonist prevents alterations of muscle diacylglycerol and adipose tissue phospholipids induced by a cafeteria diet. Nutr Metab 2004, 9:1-9.
56. Gunawardana SC, Piston DW Reversal of type 1 diabetes in mice by brown adipose tissue transplant. Diabetes 2012, 61:674-682.
57. Stanford KI, Middelbeek RJW, Townsend KL, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest 2013, 123:215-223.
58. Liu X, Zheng Z, Zhu X, Meng M, Li L, Shen Y Brown adipose tissue transplantation improves whole-body energy metabolism. Cell Res 2013, 23:851-854.
59. Cypess AM, Chen Y-C, Sze C, et al. Cold but not sympathomimetics activates human brown adipose tissue in vivo. Proc Natl Acad Sci USA 2012, 109:10001-10005.
60. Granneman JG, Lahners KN, Chaudhry A Molecular cloning and expression of the rat β3-adrenergic receptor. Mol Pharmacol 1991, 40:895-899.
61. Arch JRS β3-adrenoceptor agonists: potential, pitfalls and progress. Eur J Pharmacol 2002, 440:99-107.
62. Astrup A, Rössner S Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance. Obes Rev 2000, 1:17-19.
63. Cawthorne MA, Sennitt MV, Arch JRS, Smith SA BRL 35135, a potent and selective beta-adrenoceptor agonist. Am J Clin Nutr 1992, 55:252S-257S.
64. Whittle A, Relat-Pardo J, Vidal-Puig A Pharmacological strategies for targeting BAT thermogenesis. Trends Pharmacol Sci 2013, 34:347-355.
65. Villarroya F, Vidal-Puig A Beyond the sympathetic tone: the new brown fat activators. Cell Metab 2013, 17:638-643.
66. Bordicchia M, Liu D, Amri E, et al. Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J Clin Invest 2012, 122:1022-1036.
67. Nguyen KD, Qiu Y, Cui X, et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011, 480:104-108.
68. Bronnikov G, Houstek J, Nedergaard J β-adrenergic, cAMP-mediated stimulation of proliferation of brown fat cells in primary culture. J Biol Chem 1992, 267:2006-2013.
69. Tseng Y-H, Kokkotou E, Schulz TJ, et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 2008, 454:1000-1004.
70. Seale P, Bjork B, Yang W, et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature 2008, 454:961-967.
71. Schulz TJ, Tseng Y-H Brown adipose tissue: development, metabolism and beyond. Biochem J 2013, 453:167-178.
72. Lee Y-H, Petkova AP, Mottillo EP, Granneman JG In vivo identification of bipotential adipocyte progenitors recruited by β3-adrenoceptor activation and high-fat feeding. Cell Metab 2012, 15:480-491.
73. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481:463-468.
74. Fisher FM, Kleiner S, Douris N, et al. FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Gene Dev 2012, 26:271-281.
75. Frontini A, Vitali A, Perugini J, et al. White-to-brown transdifferentiation of omental adipocytes in patients affected by pheochromocytoma. Biochem Biophys Acta 2013, 1831:950-959.
76. Cypess AM, White AP, Vernochet C, et al. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat Med 2013, 19:635-639.
77. Jespersen NZ, Larsen TJ, Peijs L, et al. A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans. Cell Metab 2013, 17:798-805.
78. Lidell ME, Betz MJ, Leinhard OD, et al. Evidence for two types of brown adipose tissue in humans. Nat Med 2013, 19:631-634.
79. Weyer C, Tataranni PA, Snitker S, Danforth E, Ravussin E Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Diabetes 1998, 47:1555-1561.
80. Skarulis MC, Celi FS, Mueller E, et al. Thyroid hormone induced brown adipose tissue and amelioration of diabetes in a patient with extreme insulin resistance. J Clin Endocrinol Metab 2010, 95:256-262.
81. Muzik O, Mangner TJ, Leonard WR, Kumar A, Janisse J, Granneman JG 15O PET measurement of blood flow and oxygen consumption in cold-activated human brown fat. J Nucl Med 2013, 54:523-531.
82. Van Rooijen BD, van der Lans AAJJ, Brans B, et al. Imaging cold-activated brown adipose tissue using dynamic T2*-weighted magnetic resonance imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography. Invest Radiol 2013, published online May 20. 10.1097/RLI.0b013e31829363b8.
83. Ouellet V, Labbé SM, Blondin DP, et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J Clin Invest 2012, 122:545-552.